healthday3h
Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...
News Medical6h
Tirzepatide improves heart health and function in obese HFpEF patients
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...
Eli Lilly’s tirzepatide cuts risk of worsening heart failure in HFpEF, obese patients
Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, ...
2 Top Growth Stocks to Buy on the Dip
2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...
Medscape4d
GLP-1 Prescribing Decisions: Compounded or Brand-Name?
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
Altimmune's Pemvidutide Gains Momentum: Sizeable TAMs In Obesity And Liver Health
Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...
Lexaria Bioscience Corp.: Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global i ...
Why This Penny Stock Lost 13% Last Week While Markets Soared
Real-time index price for TSX Composite Weight Index (TXCE), along with buy or sell indicators, analysis, charts, historical ...
‘This Weight Loss Drug Helped My Mental Health Way More Than Any Other Medication’
The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...